Massive elimination of multinucleated osteoclasts by eupatilin is due to dual inhibition of transcription and cytoskeletal rearrangement

Ang, 2011, Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-kappaB and ERK activation, FEBS Lett., 585, 2755, 10.1016/j.febslet.2011.07.046 Cha, 2009, Essential oil of Artemisia capillaris induces apoptosis in KB cells via mitochondrial stress and caspase activation mediated by MAPK-stimulated signaling pathway, J. Food Sci., 74, T75, 10.1111/j.1750-3841.2009.01355.x Choi, 2011, Eupatilin inhibits lipopolysaccharide-induced expression of inflammatory mediators in macrophages, Life Sci., 88, 1121, 10.1016/j.lfs.2011.04.011 Dalton, 1992, Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element, Cell, 68, 597, 10.1016/0092-8674(92)90194-H Feng, 2014, Osteoclastogenesis and osteoimmunology, Front. Biosci., 19, 758, 10.2741/4242 Geusens, 2014, High-resolution in vivo imaging of bone and joints: a window to microarchitecture, Nat. Rev. Rheumatol., 10, 304, 10.1038/nrrheum.2014.23 Ho, 2014, Artemisinins: pharmacological actions beyond anti-malarial, Pharmacol. Ther., 142, 126, 10.1016/j.pharmthera.2013.12.001 Honma, 2014, Regulatory mechanisms of RANKL presentation to osteoclast precursors, Curr. Osteoporos. Rep., 12, 115, 10.1007/s11914-014-0189-0 Jeon, 2006, Bone morphogenetic protein-2 stimulates Runx2 acetylation, J. Biol. Chem., 281, 16502, 10.1074/jbc.M512494200 Ji, 2014, Controlled-release naringin nanoscaffold for osteoporotic bone healing, Dent. Mater., 30, 1263, 10.1016/j.dental.2014.08.381 Jones, 2006, Regulation of cancer cell migration and bone metastasis by RANKL, Nature, 440, 692, 10.1038/nature04524 Kim, 2014, Oleanolic acid acetate inhibits osteoclast differentiation by downregulating PLCgamma2-Ca(2+)-NFATc1 signaling, and suppresses bone loss in mice, Bone, 60, 104, 10.1016/j.bone.2013.12.013 Kim, 2014, Oleanolic acid acetate inhibits osteoclast differentiation by downregulating PLCγ2-Ca(2+)-NFATc1 signaling, suppresses bone loss in mice, Bone, 60, 104, 10.1016/j.bone.2013.12.013 Kim, 2009, Eupatilin inhibits T-cell activation by modulation of intracellular calcium flux and NF-kappaB and NF-AT activity, J. Cell. Biochem., 108, 225, 10.1002/jcb.22244 Kim, 2014, 9-Hydroxy-6,7-dimethoxydalbergiquinol inhibits osteoclast differentiation through down-regulation of Akt, c-Fos and NFATc1, Int. Immunopharmacol., 20, 213, 10.1016/j.intimp.2014.03.001 Kim, 2015, Eupatilin ameliorates collagen induced arthritis, J. Korean Med. Sci., 30, 233, 10.3346/jkms.2015.30.3.233 Kim, 2011, Histone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcription, J. Bone Miner. Res., 26, 2161, 10.1002/jbmr.426 Koga, 2004, Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis, Nature, 428, 758, 10.1038/nature02444 van der Kooy, 2013, The complexity of medicinal plants: the traditional Artemisia annua formulation, current status and future perspectives, J. Ethnopharmacol., 150, 1, 10.1016/j.jep.2013.08.021 Kwak, 2010, Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expression, Bone, 46, 724, 10.1016/j.bone.2009.10.042 Lee, 2014, Genipin inhibits RANKL-induced osteoclast differentiation through proteasome-mediated degradation of c-Fos protein and suppression of NF-kappaB activation, J. Pharmacol. Sci., 124, 344, 10.1254/jphs.13174FP Li, 1998, How Chinese scientists discovered qinghaosu (artemisinin) and developed its derivatives? What are the future perspectives?, Med. Trop., 58, 9 Li, 2014, Naringin prevents ovariectomy-induced osteoporosis and promotes osteoclasts apoptosis through the mitochondria-mediated apoptosis pathway, Biochem. Biophys. Res. Commun., 452, 629, 10.1016/j.bbrc.2014.08.117 Miralles, 2003, Actin dynamics control SRF activity by regulation of its coactivator MAL, Cell, 113, 329, 10.1016/S0092-8674(03)00278-2 Miranti, 1995, Calcium activates serum response factor-dependent transcription by a ras- and elk-1-independent mechanism that involves a Ca2+/calmodulin-dependent kinase, Mol. Cell. Biol., 15, 3672, 10.1128/MCB.15.7.3672 Morony, 2001, Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis, Cancer Res., 61, 4432 Negishi-Koga, 2011, Suppression of bone formation by osteoclastic expression of semaphorin 4D, Nat. Med., 17, 1473, 10.1038/nm.2489 Sakurai, 2014, Kinome-wide functional analysis highlights the role of cytoskeletal remodeling in somatic cell reprogramming, Cell Stem Cell, 14, 523, 10.1016/j.stem.2014.03.001 Semënov, 2005, SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor, J. Biol. Chem., 280, 26770, 10.1074/jbc.M504308200 Son, 2013, Eupatilin, a major flavonoid of Artemisia, attenuates aortic smooth muscle cell proliferation and migration by inhibiting PI3K, MKK3/6, and MKK4 activities, Planta Med., 79, 1009, 10.1055/s-0033-1350621 Suda, 1999, Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families, Endocr. Rev., 20, 345, 10.1210/edrv.20.3.0367 Takayanagi, 2002, RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta, Nature, 416, 744, 10.1038/416744a Terheyden, 2014, Inflammatory reaction — communication of cells, Clin. Oral Implants Res., 25, 399, 10.1111/clr.12176 Williamson, 2002, Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction, J. Immunol., 169, 3606, 10.4049/jimmunol.169.7.3606 Yamaguchi, 2007, Effects of flavonoid on calcium content in femoral tissue culture and parathyroid hormone-stimulated osteoclastogenesis in bone marrow culture in vitro, Mol. Cell. Biochem., 303, 83, 10.1007/s11010-007-9458-x